Anna Cohen-Rosenblum
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anna Cohen-Rosenblum has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Olivia Schaffer
Department of Orthopedic Surgery, NYU Langone Health, New York, NY 10016, USA
2 shared publications Ran Schwarzkopf
Department of Orthopedic Surgery, NYU Langone Health, New York, NY, USA
2 shared publicationsAmy Patel
Department of Endocrinology, NYU Langone Health, New York, NY, USA
1 shared publication- Arthury J. Perry
Department of Orthopedic Surgery, NYU Grossman School of Medicine, NYU Langone Orthopedic Hospital, NYU Langone Health, New York, New York
1 shared publication Brett R. Levine
MedStar Orthopedic Institute, Georgetown University School of Medicine, Washington, DC, USA
1 shared publicationChristopher Bloise
1 shared publication
Latest Publications
- Open Access
- 1 June 2026
- Published by Elsevier in Arthroplasty Today
- Vol. 39, 102026
Impact of Preoperative Osteoporotic Medications on Total Hip Arthroplasty Outcomes
- 1 June 2026
- Published by Elsevier in Arthroplasty Today
- Vol. 39, 102026
Open AccessImpact of Preoperative Osteoporotic Medications on Total Hip Arthroplasty Outcomes
- 14 May 2026
- Published by Elsevier in Journal of Clinical Orthopaedics and Trauma
- Vol. 78, 103489
What does infection cost? A comparative analysis of shoulder, hip, and knee two-stage revision procedures
- 14 May 2026
- Published by Elsevier in Journal of Clinical Orthopaedics and Trauma
- Vol. 78, 103489
What does infection cost? A comparative analysis of shoulder, hip, and knee two-stage revision procedures
- Open Access
Early Outcomes of a Novel Collared Triple-Tapered Femoral System in Primary Total Hip Arthroplasty
Background and Objectives: Collared, triple-tapered femoral stems have gained increasing popularity in primary total hip arthroplasty (THA) due to their stable metaphyseal fixation and ability to restore native hip biomechanics. This study evaluated the short-term clinical and functional outcomes of a novel collared triple-tapered femoral stem design in primary THA. Materials and Methods: This was a retrospective review of all patients who underwent primary, elective THA using a collared, triple-tapered femoral system at a single, urban, high-volume, academic hospital between September 2024 and February 2025. All procedures were performed by fellowship-trained arthroplasty surgeons. A total of 101 patients (102 hips) with a median follow-up of 1.1 years (range, 1.0 to 1.4 years) were included. Results: Most procedures were performed for primary osteoarthritis (96%). Mean operative time, from skin incision to skin closure, was 93 min, and most femoral stems implanted had a high offset (89%). Most patients were discharged home (96%), with a mean length of stay of 27 h. Within 90 days, three patients were readmitted for surgery-related reasons: one for superficial wound dehiscence, and two for periprosthetic joint infection (PJI). One PJI was treated with irrigation and debridement, antibiotics, and implant retention (DAIR) two months after primary THA. The other required a DAIR three weeks after primary THA, followed by a single-stage revision one week later. No dislocations, periprosthetic fractures, mechanical failures, or aseptic revisions of the femoral stem occurred. All stems were well-fixed at the latest follow-up, with no aseptic loosening observed. Mean Hip disability and Osteoarthritis Outcome Score, Joint Replacement (HOOS, JR) improvement was 15.0 points at six weeks, 25.2 points at three months, and 45.3 points at one year. Conclusions: Our results support encouraging early outcomes with no femoral aseptic complications observed using this novel collared, triple-tapered femoral system. A longer follow-up period is needed to assess mid- and long-term durability.
Open AccessEarly Outcomes of a Novel Collared Triple-Tapered Femoral System in Primary Total Hip Arthroplasty
Background and Objectives: Collared, triple-tapered femoral stems have gained increasing popularity in primary total hip arthroplasty (THA) due to their stable metaphyseal fixation and ability to restore native hip biomechanics. This study evaluated the short-term clinical and functional outcomes of a novel collared triple-tapered femoral stem design in primary THA. Materials and Methods: This was a retrospective review of all patients who underwent primary, elective THA using a collared, triple-tapered femoral system at a single, urban, high-volume, academic hospital between September 2024 and February 2025. All procedures were performed by fellowship-trained arthroplasty surgeons. A total of 101 patients (102 hips) with a median follow-up of 1.1 years (range, 1.0 to 1.4 years) were included. Results: Most procedures were performed for primary osteoarthritis (96%). Mean operative time, from skin incision to skin closure, was 93 min, and most femoral stems implanted had a high offset (89%). Most patients were discharged home (96%), with a mean length of stay of 27 h. Within 90 days, three patients were readmitted for surgery-related reasons: one for superficial wound dehiscence, and two for periprosthetic joint infection (PJI). One PJI was treated with irrigation and debridement, antibiotics, and implant retention (DAIR) two months after primary THA. The other required a DAIR three weeks after primary THA, followed by a single-stage revision one week later. No dislocations, periprosthetic fractures, mechanical failures, or aseptic revisions of the femoral stem occurred. All stems were well-fixed at the latest follow-up, with no aseptic loosening observed. Mean Hip disability and Osteoarthritis Outcome Score, Joint Replacement (HOOS, JR) improvement was 15.0 points at six weeks, 25.2 points at three months, and 45.3 points at one year. Conclusions: Our results support encouraging early outcomes with no femoral aseptic complications observed using this novel collared, triple-tapered femoral system. A longer follow-up period is needed to assess mid- and long-term durability.
- Open Access
- 30 March 2026
- Published by Elsevier in Arthroplasty Today
- Vol. 37 (Suppl)
Barriers to Care for Total Joint Arthroplasty Patients With Medicaid Insurance: A Survey Study of the Surgeon Perspective
- 30 March 2026
- Published by Elsevier in Arthroplasty Today
- Vol. 37 (Suppl)
Open AccessBarriers to Care for Total Joint Arthroplasty Patients With Medicaid Insurance: A Survey Study of the Surgeon Perspective
- Top Cited PapersOpen Access
- 11 June 2025
- Published by Elsevier in Arthroplasty Today
- Vol. 33, 101727
Highlights of the 2024 American Joint Replacement Registry Annual Report
- 11 June 2025
- Published by Elsevier in Arthroplasty Today
- Vol. 33, 101727
Top Cited PapersOpen AccessHighlights of the 2024 American Joint Replacement Registry Annual Report